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INTRODUCTION 1 
Our view of oral streptococci has largely been influenced by the approach taken in 2 
the last century to identify etiologic agents of disease. As a consequence, beneficial 3 
aspects of streptococcal colonization of the oral cavity were initially overlooked. The first 4 
comprehensive analysis of the resident oral microbiota was accomplished in 2005 (1) and 5 
with this, a new picture began to emerge. With the availability of high throughput 6 
sequencing techniques and an increased sensitivity in analysis methods, the presence of 7 
a defined microbiome associated with oral health has been shown (2). Alongside this, 8 
‘omics’ techniques have revealed that prevalent oral diseases such as caries and 9 
periodontal disease are polymicrobial in nature and the result of microbial dysbiosis (3, 4). 10 
Even more striking, the metabolic output of these mixed microbial communities seems to 11 
be more relevant than their precise microbial composition (4). This is also reflected by the 12 
fact that the severity of caries and periodontal disease is heavily influenced by the 13 
synergistic interactions of the individual members of the polymicrobial consortium, 14 
including metabolic cross-feeding and interspecies signaling with transcriptional 15 
adjustment to the metabolic output. Thus, the ecological context of the microbial 16 
community seems to be of importance to understand oral health and disease 17 
development. As a consequence, polymicrobial diseases cannot be explained by the 18 
behavior of one bacterial species and certainly cannot be treated like diseases that follow 19 
Koch’s postulates (5-7). Novel approaches to combat oral polymicrobial diseases should 20 
therefore focus on the bacterial community that is present in the healthy oral cavity. Since 21 
oral streptococci are abundant during initial colonization of the tooth (8, 9), their function 22 
is to provide a favorable environment for incorporation of later species and to support 23 
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accretion of the mature oral biofilm, which in general has a health-protecting function (10, 24 
11). 25 
One of the oral Streptococcus species that is repeatedly isolated in great 26 
abundance as part of the health-associated microbiome is the initial colonizer 27 
Streptococcus sanguinis (12-14). Because of the strong association of S. sanguinis with 28 
oral health, this commensal can serve as a model to understand how an individual species 29 
is able to interact with other members of the bacterial community to shape the composition 30 
of a benign oral biofilm. S. sanguinis is in general classified as a non-spore-forming, 31 
catalase-negative, chain-forming coccus. S. sanguinis is non-beta-hemolytic, but is able 32 
to produce a green coloration on blood agar plates referred to as alpha-hemolysis, which 33 
is a consequence of hydrogen peroxide (H2O2) production (15). S. sanguinis has been 34 
placed into the mitis group of streptococci based on 16S rRNA sequence analysis; 35 
however, it has also been classified in its own group together with S. gordonii and S. 36 
parasanguinis (15). A more recent analysis using the housekeeping genes rpoB, sodA, 37 
ddl, and gdh showed a more distant relationship with S. parasanguinis, but confirmed the 38 
phylogenetic relationship with S. gordonii (16). Here we present the sanguinis-group 39 
streptococci in the context of molecular commensalism, highlighting those aspects of their 40 
biology that are important for health-associated biofilm development, including 41 
polymicrobial interactions, regulatory and mechanistic events (Figure 1). 42 
 43 
MOLECULAR DETERMINANTS OF S. SANGUINIS AS A COMMENSAL PIONEER 44 
COLONIZER 45 
Initial colonization is intimately linked to the adhesion capabilities of oral 46 
streptococci. S. sanguinis, together with S. gordonii, S. oralis and S. mitis, are well 47 
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adapted for initial colonization. These streptococci express a multitude of bacterial surface 48 
proteins, named adhesins, which are able to interact with salivary proteins covering the 49 
tooth surface (17-19). S. sanguinis seems to be particularly well equipped with adhesins 50 
that recognize this salivary pellicle (20). Overall, initial colonization has two important 51 
consequences. First, the ecological niche is occupied, which plays a significant role in the 52 
process of colonization resistance and the exclusion of potential incoming pathogens. 53 
Second, initial colonization shapes the overall composition of the biofilm, since the pioneer 54 
colonizer can produce metabolic products or provide a substratum for compatible partner 55 
species. Initial biofilm development requires the formation of macromolecular complexes. 56 
Complex formation is facilitated through electrostatic interactions of salivary proteins with 57 
the tooth surface to form the acquired enamel pellicle, a process that occurs within 58 
seconds after a clean enamel surface is exposed to saliva (21). Microbial attachment to 59 
the acquired enamel pellicle is then mediated via protein-protein and lectin-like 60 
interactions. The protein content of the acquired enamel pellicle is thus a major 61 
determinant of colonization sequence, dictating strength of microbial adhesion as well as 62 
localization, since pellicle proteins seem to differ according  to anatomical site (22).  63 
A prominent protein in saliva and the acquired enamel pellicle is -amylase, 64 
responsible for the catalytic hydrolysis of starch (23, 24). Amylase binding proteins have 65 
been identified in several oral streptococcal species (24). Best studied is the amylase-66 
binding protein A (AbpA) in S. gordonii (25). Mutation of AbpA results in deficient biofilm 67 
formation and bacterial adhesion in vitro (26). Although the sequenced reference strain S. 68 
sanguinis SK36 seems to encode an abpA homolog in a similar chromosomal context with 69 
its accessory sortase, srtB (27), its function is currently unknown. Interestingly, S. 70 
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sanguinis is able to bind directly to surface-bound amylase and vice versa (24). This 71 
function has been shown to be mediated by long filamentous pili, organized in a four-72 
gene operon (ssa1631-1634) that encodes three pilin subunits (PilA-C) and a dedicated 73 
sortase, SrtC, for cell-surface anchoring of the pilin structural proteins (28). Pili are 74 
relatively long and thin appendages and the pili of S. sanguinis can be as long as 1 µm, 75 
as shown by immune-gold staining of PilA (28). This poses a potentially interesting 76 
dynamic with AbpA, which is strictly confined to the outer cell surface, as shown for S. 77 
parasanguinis, also with immune-gold labeling (27). Taking into account that pili are 78 
flexible, one could hypothesize that binding to amylase in acquired enamel pellicle is 79 
possible even when the molecule is scarce, since the pili could serve as a flexible “arm”, 80 
latching onto free amylase within saliva. A recent publication demonstrating that 81 
amylase in acquired enamel pellicle is actually less abundant when compared to saliva 82 
(29) is in agreement with this hypothesis, suggesting an advantage of a flexible “arm” over 83 
a rigid arrangement on the bacterial surface. The pili also showed binding to other salivary 84 
proteins and their deletion diminished biofilm formation on saliva-coated surfaces (28). 85 
However, the mutant was still able to bind amylase, albeit with lower efficiency (28), 86 
suggesting that other surface proteins are also able to bind amylase, possibly the 87 
aforementioned AbpA homolog (27). A pilus-bound amylase also offers the advantage of 88 
retaining about 50% of its enzymatic function (30). Gaining access to the amylase 89 
substrate starch through a flexible pilus would increase the chance for hydrolysis of the 90 
alpha-1,4-glycosidic linkage into glucose, maltose and maltodextrins, promoting sugar 91 
uptake and subsequent metabolism by simply increasing the accessible radius of the cell. 92 
 Two major mucins are found in saliva, MUC7 (low molecular weight) and MUC5B 93 
(high molecular weight) (31, 32). The majority of mucins are synthesized and secreted 94 
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by the submandibular and sublingual glands, as well as minor glands located in the 95 
palatal, buccal and labial mucosae. Mucins are heavily glycosylated glycoproteins and 96 
form a lubricating, viscoelastic coating on all oral surfaces. They are abundant proteins 97 
in saliva and the acquired enamel pellicle (31, 32). Both MUC7 and MUC5B contain 98 
sialic acid as a glycoconjugate and this can be targeted by S. sanguinis SK36 sialic-99 
acid-binding adhesin SrpA (33). SrpA contains a subdomain in its binding region that is 100 
similar to the V-set Ig-like fold adopted by mammalian Siglecs (sialic acid-binding 101 
immunoglobulin-like lectins) (34, 35). Indeed, Siglec-like domains have been identified 102 
in potential adhesins of several S. sanguinis isolates and other oral streptococci (34). 103 
Glycoarray dot blots with human salivary samples and naturally occurring 104 
glycoconjugates have demonstrated a high specificity of S. sanguinis SK36 SrpA for 105 
MUC7, but no binding to MUC5B. This is in contrast to S. gordonii, which showed in 106 
general better binding to several glycoconjugates, including MUC5B and amylase (34), 107 
which are known to form a heterotypic complex (36). As mentioned above, amylase and 108 
MUC5B seem to be depleted in the acquired enamel pellicle compared to saliva (29), 109 
but this was not seen for MUC7. Thus specificity of binding to MUC7 within the acquired 110 
enamel pellicle may go some way to explain why S. sanguinis seems to be one of the 111 
first oral colonizers and found in greater abundance compared to S. gordonii. The 112 
glycoarray also revealed an interesting role for divalent cations Ca2+ and Mg2+ in the 113 
binding of S. sanguinis SK36 to MUC7, as well as to other glycoconjugates (34). 114 
Chelation of Ca2+ and Mg2+ decreased binding to several of the tested components. 115 
This was also observed with two S. gordonii strains (34), suggesting a dominant role 116 
for divalent cations in the binding process of not only S. sanguinis, but of other oral 117 
streptococci to salivary components and the acquired enamel pellicle. This is further 118 
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supported by the increased abundance of proteins known to bind divalent cations like 119 
Ca2+ in the acquired enamel pellicle compared to saliva (29). Interestingly, S. sanguinis 120 
encodes a surface-associated, dual-function protein that bridges substratum 121 
attachment and interactions with divalent cations. SsaB is able to bind to saliva-coated 122 
hydroxyapatite through an unknown mechanism (37), but its principal function seems 123 
to be the transport of divalent cations (38). While this transport was demonstrated to be 124 
specific for Mn2+ and Fe2+, playing a pivotal role in oxidative stress defense (38), other 125 
divalent cations like Ca2+ and Mg2+ might still be able to interact with SsaB to facilitate 126 
binding to the acquired enamel pellicle. 127 
Recently the ability of S. sanguinis to be motile on surfaces like solidified agar has 128 
been reported for several strains. Spreading zones after prolonged incubation can be 129 
observed around colonies, indicating active movement (39). Whether or not this so-called 130 
‘twitching motility’ has any function or is used as a means to disseminate within the oral 131 
biofilm is not yet clear. However, the pil locus that encodes the type IV pilus involved in 132 
twitching motility is conserved in most of the sequenced S. sanguinis genomes (39), 133 
suggesting biological importance. 134 
Overall, S. sanguinis does not rely on a single mechanism to bind and establish 135 
itself within the acquired enamel pellicle. Rather the process is elaborate and ensures 136 
the role of S. sanguinis as a pioneer colonizer. This correlates with the observation that 137 
signal peptidase I is required for biofilm development (40). In general, signal peptidases 138 
are membrane-bound endo-proteases that cleave the signal peptide portion from the 139 
majority of secreted proteins (41). S. sanguinis encodes two signal peptidases, 140 
SSA_0849 and SSA_0351, which are crucial for biofilm formation. Deletion of 141 
SSA_0351 abolishes biofilm formation but does not affect planktonic growth. Although 142 
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the substrates for signal peptidase processing are not experimentally verified, in silico 143 
prediction identified 168 potential candidates, including several adhesins (40). Further 144 
characterization of signal peptidase processed surface proteins will most likely identify 145 
new proteins involved in the adhesion process. 146 
 147 
S. SANGUINIS IN BIOFILM FORMATION 148 
The initial step in biofilm development is attachment, followed by micro-colony 149 
formation of newly attached cells through growth expansion. This process then leads into 150 
a series of ordered and temporal events, in which coadhesion predominates, ultimately 151 
resulting in formation of a mature biofilm. The production of extracellular matrix material 152 
is a defining step in biofilm development and maturation. Matrix materials include 153 
polymers such as carbohydrates, proteins, extracellular DNA (eDNA) and lipids, and are 154 
collectively referred to as extracellular polymeric substances (EPS) (42). Since EPS is 155 
produced by the biofilm inhabitants themselves, specific enzymatic functions and cellular 156 
processes are associated with its formation. 157 
 Exploiting the intake of dietary sugars, many oral Streptococcus species have 158 
evolved glucosyltransferases (Gtfs) that hydrolyze sucrose and polymerize the glucose 159 
into glucans. These, in turn, promote biofilm development. A single Gtf, GtfP, is carried 160 
on the S. sanguinis genome, which synthesizes mainly water-soluble -1,6-linked glucans 161 
that branch at -3,6-linked glucose residues (43). TetR family regulator BrpT was recently 162 
identified as a repressor of gtfP expression. While a gtfP mutant formed only a fragile 163 
biofilm, the biofilm formed by the brpT mutant was thicker, more robust, and with a higher 164 
glucan content (44). By modulating levels of glucan synthesis, BrpT may therefore control 165 
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switching of S. sanguinis biofilms from an adherent to a dissemination state. S. gordonii 166 
also carries a single gtf gene, gtfG, encoding an enzyme that synthesizes both -1,3- and 167 
-1,6-linked glucans. This activity was found to promote mixed biofilm formation with 168 
Candida albicans (45), and a gtfG mutant was unable to persist on the tooth surface in 169 
rats (46). Expression of GtfG is under the positive regulation of Rgg (47), a homolog of 170 
which is present in S. sanguinis. As for other oral streptococci, it is likely that expression 171 
of Gtfs and thus glucan content of biofilms is a tightly controlled process, affected by 172 
multiple factors and transcriptional regulators. 173 
 Compared to carbohydrates, the presence of eDNA within EPS is a relatively 174 
recent discovery. Nonetheless, growing evidence suggests that eDNA is a critical 175 
contributor to cell-to-cell adherence and overall biofilm stability (48). Courtesy of its 176 
negative charge, eDNA may facilitate association with the acquired salivary pellicle (49), 177 
and cell aggregation was shown to be promoted by eDNA for S. sanguinis, although not 178 
for S. gordonii (50). Visualization of ‘yarn’ and ‘sweater’ structures of eDNA that wrap 179 
around cells within Enterococcus faecalis biofilms (51) provides compelling evidence for 180 
how eDNA may contribute to the structural integrity of biofilms, and similar structures have 181 
been seen for biofilms of S. gordonii (A.H. Nobbs, unpublished data). Moreover, eDNA 182 
regulates the viscoelastic properties of biofilms that allows them to withstand mechanical 183 
stress (52), a property that is particularly pertinent to the oral cavity environment. In line 184 
with this, the presence of DNABII proteins within EPS of S. gordonii and other oral 185 
bacterial biofilms was recently found to be essential for eDNA integrity and biofilm 186 
structure (53). The regulation of eDNA release is not fully understood, and both lytic and 187 
active mechanisms have been reported. For S. sanguinis and S. gordonii, autolysins LytF 188 
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and AtlS play significant roles via mechanisms closely linked to H2O2 production and 189 
competence development. These are discussed in more detail later. 190 
 Multicellular entities such as biofilms require a high level of coordination, and 191 
quorum sensing (QS) circuits and two component signaling systems (TCS) are intimately 192 
involved in these processes. One QS system found across several bacteria is LuxS/AI-2. 193 
LuxS is an integral component of the activated methyl cycle (AMC) for correct methylation 194 
of nucleic acids and proteins, but as a by-product of this cycle generates autoinducer 2 195 
(AI-2), an interspecies chemical signal. LuxS mutants in S. gordonii and S. sanguinis were 196 
altered in their ability to form biofilms, and lack of AI-2 resulted in altered S. gordonii 197 
microcolony architecture (54). However, a definitive role for AI-2 has not been identified 198 
and for S. sanguinis, a disrupted AMC rather than absence of AI-2 was found to underpin 199 
the luxS mutant biofilm phenotype (55). A TCS associated with regulation of biofilm 200 
formation for both S. sanguinis and S. gordonii is BfrAB (56). This modulates expression 201 
of two ABC transporters (BfrCD, BfrEFG) and a putative membrane-bound 202 
metalloprotease (BfrH). Given such functions, it is postulated that this system transports 203 
and processes proteins or peptides across the cell membrane that promote biofilm 204 
development, although the precise targets have yet to be identified. More recently, defects 205 
in TCS SptRS have been found to promote biofilm formation by S. sanguinis, associated 206 
with elevated levels of H2O2 and eDNA (57), while standalone ArcR was identified as a 207 
key regulator of S. gordonii biofilm development, perhaps via modulation of the 208 
phosphotransferase system (58). 209 
 A final aspect of streptococcal biology that is closely associated with biofilm 210 
formation is competence development. This is a QS system that controls transformation, 211 
i.e. the capacity for bacteria to actively take up exogenous eDNA, and in species such as 212 
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S. sanguinis and S. gordonii, is regulated via the comCDE operon (59, 60). Gene comC 213 
encodes a precursor molecule that is cleaved and exported via ABC transporter ComAB, 214 
releasing the mature competence stimulating peptide (CSP) into the local environment. 215 
For S. gordonii this is a 19-amino acid peptide, while the CSP of S. sanguinis is 17-amino 216 
acid residues, thereby minimizing interspecies cross-talk. The CSP is sensed by TCS 217 
ComDE. Once the CSP pheromone exceeds a threshold concentration, ComD 218 
phosphorylates ComE, which upregulates expression of early competence genes 219 
including comCDE and comAB, establishing a positive feedback loop, and comX. ComX 220 
then drives expression of the late competence genes required for DNA binding, uptake 221 
and recombination. The coordination of competence and biofilm development contributes 222 
to the adaptability of bacteria such as S. sanguinis to changing environmental conditions 223 
via horizontal gene transfer (HGT). This will be explored in more detail later. 224 
 225 
S. SANGUINIS IN COMMUNITY DEVELOPMENT 226 
 S. sanguinis and S. gordonii can form monospecies biofilms, but within the host the 227 
biofilm communities are typically polymicrobial in nature. As pioneer colonizers, these 228 
streptococci can have profound consequences for niche occupation and subsequent 229 
colonization by incoming species and thus significantly influence whether a community is 230 
predisposed to health or disease. Such interactions do not occur at random, but rather 231 
are directed in an ordered and temporal manner as a consequence of direct physical 232 
engagement (coadhesion), metabolic relationships and interspecies communication. 233 
 Alongside streptococci, Actinomyces species constitute the predominant, health-234 
associated early colonizers of the oral cavity, and both S. sanguinis and S. gordonii are 235 
able to coadhere with Actinomyces oris. This is mediated by recognition of streptococcal 236 
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receptor polysaccharide (RPS) containing linkages GalNAcβ1-3Gal or Galβ1-3GalNAc by 237 
the FimA subunit of A. oris type 2 fimbriae (61, 62), with variations in the genetic loci for 238 
synthesis of RPS (rps) and RPS precursors (rml, galE1, galE2) subtly altering the 239 
coadhesion profile with different streptococcal species (63). In addition, S. gordonii 240 
antigen I/II family protein SspB targets an extracellular polysaccharide produced by A. 241 
oris, although the precise composition and structure of this polysaccharide has yet to be 242 
determined (64). Once bound, A. oris may then promote S. gordonii survival under low 243 
arginine conditions by stabilization of arginine biosynthesis (65). Similarly, S. gordonii 244 
adhesin Hsa binds surface receptor Hag1 of early colonizer Veillonella species (66), but 245 
this interaction is also underpinned by a strong metabolic dependency. Lacking a fully 246 
functional glycolytic pathway, veillonellae must utilize hydroxyl acids for growth. These 247 
are provided by streptococci as excreted metabolic waste product lactate and utilization 248 
of lactate, in turn, protects streptococci from low pH (67). Once established, this 249 
community of pioneer colonizers then supports the incorporation of secondary or late 250 
colonizers, with Fusobacterium nucleatum serving as an important ‘bridging’ organism 251 
due to its promiscuous coadhesion capabilities. S. sanguinis supports this engagement 252 
via interaction with the arginine-inhibitable adhesin RadD of F. nucleatum (68), while a 253 
second fusobacterial outer membrane protein, coaggregation mediating protein A 254 
(CmpA), has recently been shown to promote biofilm formation with S. gordonii (69). 255 
 These community interactions with compatible species illustrate how sanguinis-256 
group bacteria are able to promote development of a health-associated microbiota. 257 
Nonetheless, the social life of these bacteria is not exclusively beneficial and other 258 
microbial partnerships may facilitate a more disease-prone state. Such examples have 259 
largely been described for S. gordonii, rather than for S. sanguinis, leading to the 260 
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designation of S. gordonii as an ‘accessory pathogen’. Some of the best characterized 261 
interactions are with periodontopathogens Porphyromonas gingivalis (70, 71) and 262 
Aggregatibacter actinomycetemcomitans (72), and with fungal pathogen C. albicans (73). 263 
Evidence from in vitro studies and animal models shows that these relationships can 264 
enhance both the persistence and virulence potential of the microbes involved (74).  265 
 Chemical communication in modulation of the oral microbial community is 266 
exemplified by the complex effects of interspecies signaling molecule AI-2. This molecule 267 
promotes dual species biofilm formation between S. gordonii and S. oralis but can also 268 
modulate the relative proportions of these species in a concentration-dependent manner 269 
(75). Likewise, while AI-2 from F. nucleatum promotes biofilm development with S. 270 
gordonii, it has the opposing effect on S. oralis (76). AI-2 from S. gordonii is essential for 271 
mutualistic biofilm growth with A. oris (77), but may also promote biofilm formation with P. 272 
gingivalis (78) and C. albicans (79). Ultimately, QS molecules and peptide pheromones 273 
work together with the molecular mechanisms described above to exquisitely coordinate 274 
biofilm development. The result is a community optimized to survive and persist under the 275 
prevailing environmental conditions in a manner that exceeds the capabilities of the 276 
individual component species.    277 
 278 
COMPETITIVE BEHAVIOR - INHIBITION BY S. SANGUINIS H2O2 AND BACTERIOCIN 279 
PRODUCTION 280 
Addressed above are examples of synergistic interactions with sanguinis-group 281 
streptococci that promote incorporation and retention of the partner microbes within the 282 
biofilm community. Nonetheless, within a defined ecological niche, resources are limited 283 
and thus, competitive forces also work to shape the developing biofilm. One of the best 284 
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investigated competitive measures of S. sanguinis (and the vast majority of oral 285 
streptococci) is the production of H2O2 (80). The enzyme responsible for the production of 286 
H2O2 is pyruvate oxidase, SpxB (81, 82). SpxB is encoded by the majority of commensal 287 
oral streptococci, with an unusually high degree of conservation of over 96% amino acid 288 
identity when compared to SpxB of S. sanguinis strain SK36. SpxB catalyzes the 289 
conversion of pyruvate to acetyl phosphate, CO2, H2O2, and ATP. Therefore, besides 290 
generating inhibitory amounts of H2O2, SpxB confers a growth advantage on the producer 291 
via ATP generation during biofilm development (81, 82). 292 
The overall importance of H2O2 production is further indicated by the fact that 293 
neither S. sanguinis nor spxB-encoding oral streptococci seem to encode for the H2O2 294 
detoxifying enzyme catalase. Consequently, these bacteria are able to produce 295 
considerable amounts of H2O2 that can influence the surrounding environment and inhibit 296 
susceptible species. H2O2-dependent competitive behavior faces two challenges. First, 297 
SpxB requires oxygen for its activity (83, 84). Its production therefore declines once biofilm 298 
formation reaches a certain density resulting in an anaerobic environment. Second, 299 
released H2O2 is a substrate for detoxifying enzymes like salivary lacto-peroxidase (85). 300 
Therefore, the effect of H2O2 production on biofilm development is confined to the 301 
immediate vicinity of the producer and most likely does not result in active killing of 302 
competitors.  Rather, H2O2 will affect susceptible species just enough to gain a growth 303 
advantage. For S. sanguinis, the oxygen dependent production of H2O2 makes perfect 304 
sense from an ecological point of view. As initial colonizer, S. sanguinis finds a sparse 305 
inhabited environment with enough salivary oxygen tension to promote H2O2 production 306 
(86). However, once biofilm growth through proliferation and integration of compatible 307 
species is sufficient to result in a decline in oxygen tension, S. sanguinis will already be 308 
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an established member of the community and so H2O2 production is no longer required 309 
(80). The inhibitory spectrum of H2O2 as evaluated in vitro with deferred antagonism plate 310 
assays includes cariogenic S. mutans, as well as periodontopathogens A. 311 
actinomycetemcomitans, Prevotella intermedia and P. gingivalis (83, 87). 312 
The genetic regulation of spxB expression holds a mystery. A clear repressive 313 
function of the carbon catabolite repressor CcpA has been shown since deletion of CcpA 314 
in S. sanguinis strain SK36 lifts spxB repression (88). Further, two cre sites (carbon 315 
responsive element) for the binding of CcpA have been verified experimentally (89), yet 316 
no glucose effect on spxB expression and H2O2 production can be observed. This is in 317 
contrast to other species like S. gordonii, which follows classic carbon catabolite 318 
repression in the presence of glucose (90). Why CcpA in S. sanguinis does not respond 319 
to the presence of glucose, and if any environmental factor influences spxB expression, 320 
has yet to be determined. Compared to S. gordonii and other oral streptococci, S. 321 
sanguinis H2O2 production in general seems to be less (89, 91) and a clue to the 322 
consequences of low H2O2 production and tight control by CcpA might be explained by 323 
the increased susceptibility of a S. sanguinis CcpA knockout mutant towards its own H2O2 324 
production (88). However, whether or not this is a direct effect of H2O2 or the result of 325 
altered gene expression from other CcpA-controlled genes is not currently known. From 326 
the ecological standpoint, the numerical abundance of S. sanguinis over other species 327 
might not require high production of H2O2 while other species like S. gordonii, known to 328 
be a less prominent member of the oral biofilm, might require more aggressive H2O2 329 
production to establish itself within the oral community. Taking into account that oral 330 
streptococci intermingle during biofilm formation and can be found at the same location 331 
(92), the sum of H2O2 production could be more important than the quantity produced by 332 
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individual species. Nevertheless, competitive H2O2 production and its role in community 333 
development is important and can be used to study biofilm dynamics. 334 
Interestingly, S. sanguinis is also able to produce antimicrobial activity via 335 
bacteriocins. Several reports describe the antimicrobial activity of sanguicins (93, 94). 336 
Initial characterization showed bacteriostatic activity against a number of oral species, 337 
including A. naeslundii, but not periodontopathogens P. gingivalis, P. intermedia and F. 338 
nucleatum (53). However, a more recent study using purified sanguicin demonstrated 339 
antimicrobial activity against such pathogens (93). Since both studies used a different 340 
strain of S. sanguinis and reported different molecular weights (65 kDa vs 280 kDa) for 341 
the purified peptide, it is most likely that different sanguicins were characterized. It is also 342 
worth mentioning that none of the studies determining the effect of H2O2 on 343 
periodontopathogens or S. mutans reported an inhibitory effect when catalase was added 344 
to the deferred antagonism assay (87, 95). Therefore, either strain-specific antagonistic 345 
activity exists, or the culture conditions used in the studies were selective for specific 346 
production of bacteriocins or H2O2. 347 
  S. sanguinis bacteriocins are also reported to exhibit anti-fungal activity (96, 97). 348 
As part of the normal microbiota, C. albicans is commonly isolated from subjects, but can 349 
also cause problems like oral candidiasis (98). S. sanguinis produces a bacteriocin that 350 
can cause changes in cell surface hydrophobicity of several Candida spp., a factor that 351 
influences the initial adhesion of Candida to oral epithelium. Furthermore, the bacteriocin 352 
can impair fungal cell membrane permeability and general cell structure (96, 97). How this 353 
ultimately affects survival of the fungal cell in vivo is not known but, analogous to the effect 354 
of H2O2 production, it might provide a competitive advantage to S. sanguinis by impairing 355 
growth of competing oral fungi. 356 
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 357 
HORIZONTAL GENE TRANSFER AND ANTIBIOTIC RESISTANCE RESERVOIR 358 
An important feature of oral streptococci is the ability to take up eDNA when 359 
developing competence, as discussed earlier. While the process of competence 360 
development is well characterized at the molecular level (99), the origin of DNA in the 361 
environment and the molecular mechanisms of DNA release from bacterial cells are less 362 
well understood. As a vital part of the oral biofilm matrix, eDNA available for uptake by 363 
competent bacteria is quite abundant (100, 101). In general, cell lysis can contribute to 364 
the release of DNA from bacterial cells. This process can be an active autolysis process 365 
involving murein hydrolases that weaken or completely lyse the cell wall, consequently 366 
expelling DNA into the environment (102). Interestingly, both S. sanguinis and S. gordonii 367 
release DNA in a H2O2-dependent manner under aerobic conditions (83). The eDNA is 368 
largely intact, high molecular weight DNA of chromosomal origin. Release of eDNA peaks 369 
when S. sanguinis grows aerobically under optimal H2O2-producing conditions and release 370 
declines when cells are grown under oxygen-limiting conditions, when no H2O2 is 371 
produced. Furthermore, deletion of spxB severely impacts the release (83). However, 372 
eDNA release can be induced even under anaerobic conditions with the addition of H2O2, 373 
as shown for S. gordonii, but only when cells are metabolically active (103). Addition of 374 
H2O2 to cells suspended in buffer will not release DNA, indicating the requirement for 375 
active metabolism, gene expression or protein synthesis. This is also consistent with the 376 
observation of a time delay between the production of H2O2 and the appearance of the 377 
released DNA, and the evidence that addition of chloramphenicol, known to block 378 
synthesis of new proteins, also blocks release of DNA (103). This is relevant in the context 379 
of the oral biofilm, where SpxB-positive streptococci that have access to oxygen can 380 
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produce H2O2 that might then diffuse through the oral biofilm with limited or no oxygen. 381 
Remarkably, the H2O2-dependent release of DNA is not the result of obvious cell lysis 382 
(50), as reported for other streptococci like S. pneumoniae (104). Although the exact 383 
molecular mechanism involved in the release is not known at this moment, S. sanguinis 384 
might encode a dedicated system for eDNA release. This could involve partial lysis and/or 385 
active transport across the membrane. In a recent study, the transport of eDNA in H. 386 
influenzae was found to be dependent upon competence-related protein ComE (105), the 387 
transporter involved in the uptake of DNA. S. sanguinis encodes for ComE and intriguingly 388 
expression of competence genes seems to be increased under aerobic conditions ideal 389 
for H2O2 production in streptococci (83, 103). However, experimental evidence that this 390 
mechanism is conserved in S. sanguinis is not available. When grown under anaerobic 391 
conditions, eDNA release is not completely absent suggesting another mechanism 392 
involved in the release (50). One autolytic enzyme involved in this process in S. sanguinis 393 
is LytF, also under the control of the competence system as one of the early competence 394 
genes (106). LytF is a secreted autolysin and can be recovered from the environment in 395 
its active form. LytF is a fratricin, but also acts on neighboring cells causing release of 396 
eDNA not only from S. sanguinis but also other streptococci (106). In general, streptococci 397 
seem to control or connect competence development with the release of eDNA (107), 398 
exemplifying their role as masters of efficacy. Utilizing this approach increases the chance 399 
that DNA is available for uptake and transformation. 400 
Uptake of eDNA has two pronounced functions; first, it serves in horizontal gene 401 
transfer during bacterial transformation and therefore plays a pivotal role in the promotion 402 
of diversity among oral bacterial species, and is an important mechanism of evolution 403 
allowing the acquisition of new genetic traits stored in the genomic information contained 404 
  19 
in the multispecies biofilm (108). Second, eDNA in the oral cavity can serve as a reservoir 405 
for diverse antibiotic resistance mechanisms (109). A recent comparison of S. sanguinis 406 
and S. gordonii genomes revealed the presence of several genes potentially associated 407 
with antibiotic resistance determinants, including GNAT acetyltransferases, parE, and 408 
TetR family regulators (110). Combined they potentially provide resistance to diverse 409 
antibiotics like aminoglycosides, fluoroquinolones and many more. Additionally, several 410 
genes were identified encoding anion channels in S. sanguinis that confer resistance to 411 
fluoride (111), particularly important since fluoride is successfully used to prevent caries. 412 
Although the direct transfer of antibiotic resistance determinants via eDNA from other 413 
species to S. sanguinis has not been confirmed, evidence exists that in general the 414 
acquisition of new genetic traits occurs. For example, the pathway for vitamin B12 415 
biosynthesis as well as the degradation of ethanolamine and propanediol, which are 416 
encoded on a large genomic region, has been acquired through horizontal gene transfer 417 
(112), although it is unknown if this was mediated through conjugation, transduction or 418 
transformation. The best evidence for the potential of H2O2-induced transfer of antibiotic 419 
resistance was shown with S. gordonii, using engineered strains carrying antibiotic 420 
resistance cassettes. Co-incubation of strains encoding distinct antibiotic cassettes under 421 
ideal H2O2-producing conditions increased the occurrence of intraspecies genetic 422 
exchange by 300-fold when compared to non-permissive conditions (103). Overall, 423 
antibiotic resistance in the oral biofilm seems to be mainly acquired through horizontal 424 
gene transfer as suggested by a recent review (113). The dental biofilm is an ideal 425 
environment for the development and transfer of antibiotic resistance, even under 426 
conditions where no external pressure through antibiotic administration is present. This is 427 
supported by the finding that biofilm evolution and selective pressure through competitive 428 
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bacterial interactions mediated by bacteriocins alone gave rise to antibiotic resistance 429 
(114). The oral microbiome is able to elicit this evolutionary pressure due to the 430 
abundance of bacteriocins (115). 431 
 432 
S. SANGUINIS AS A MODULATOR OF THE HOST 433 
While the predominant ecological niche of S. sanguinis is the tooth surface, dental 434 
plaque formed at the gingival margin brings the oral biofilm into contact with the oral 435 
epithelium and associated immune defenses. The host-microbe interplay that occurs at 436 
these sites represents a critical step in determining progression of the biofilm community 437 
below the gum line, and potential transition from oral health to onset of gingivitis, 438 
periodontitis or other disease manifestations. Another facet of the S. sanguinis persona 439 
as coordinator of the microbial community is therefore its interactions with host tissues. 440 
  Under conditions of oral health, an equilibrium exists between microbiota and host, 441 
representing a delicate balance of antimicrobial factors from immune cells, together with 442 
pro- and anti-inflammatory molecules released from the host in response to the sustained 443 
microbial challenge. By contrast, disruption of this homeostasis is the hallmark of chronic 444 
inflammatory periodontal disease and resultant tissue damage. In keeping with this, S. 445 
sanguinis biofilms were found to be a poor stimulant of proinflammatory cytokines IL-1 446 
IL-6 and IL-8 from OKF4 oral epithelial cells compared to biofilms of F. nucleatum (116). 447 
Likewise, in contrast to cell wall extracts of F. nucleatum or P. gingivalis, those of S. 448 
sanguinis failed to induce significant upregulation by gingival keratinocytes of genes 449 
encoding human β defensin peptides, proinflammatory cytokines (e.g. IL-8) or matrix 450 
metalloproteinase-9. These keratinocyte responses were mediated by TLR2, with 451 
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differences in acylation patterns of bacterial lipopeptides purported to underpin the 452 
differential outcomes of TLR2 stimulation by the bacterial species (117). Moreover, while 453 
only a weak stimulant of host responses itself, S. sanguinis is also able to suppress the 454 
effects of other microbes. In mixed culture, S. sanguinis impaired induction of IL-8 release 455 
from gingival HOK-18A epithelial cells by A. actinomycetemcomitans. Such effects were 456 
also seen with S. sanguinis spent culture medium alone, implying a secreted molecule as 457 
the mediator (118). Similarly, through blocking LPS engagement with monocyte receptors 458 
LPS-binding protein (LBP) and CD14, peptidoglycan from S. sanguinis was able to inhibit 459 
induction of genes encoding TNF, IL-6 and IL-8 by periodontopathogens P. gingivalis, 460 
A. actinomycetemcomitans and Tannerella forsythia (119). This mechanism correlates 461 
well with the observation that Gram-positive bacteria release large quantities of 462 
peptidoglycan fragments, muropeptides, during cell division (120). Such coordination of 463 
both host responses and of the oral microbiota is likely critical to the role of S. sanguinis 464 
as a health-associated member of the oral biofilm community.       465 
 466 
S. SANGUINIS AS AN ETIOLOGICAL AGENT OF EXTRAORAL DISEASES 467 
Despite its main role as a benign oral commensal, the name S. sanguinis derives 468 
from its role in cardiovascular disease infective endocarditis (IE). In a note to the Journal 469 
of Bacteriology, Niven and White described a new species isolated from approximately 470 
100 cases of subacute bacterial endocarditis (121). About one third of the isolates failed 471 
characterization as previously described streptococci and were referred to as 472 
Streptococcus s.b.e. (for subacute bacterial endocarditis) (121). Overall the group was 473 
quite homogeneous in its physiological characteristics (122). Further serological 474 
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characterization confirmed the isolation of a new species since no cross reactivity was 475 
observed between rabbit serum from Streptococcus s.b.e. and other identified 476 
streptococci belonging to various Lancefield groups (123). Interestingly, isolation of 477 
Streptococcus s.b.e. from the human throat was unsuccessful at that time, despite testing 478 
over 800 streptococcal isolates. The only other positive culture came from an extracted 479 
tooth, which we now know coincides with the preferred colonization site. However, in the 480 
original publication, the natural habitat was not identified and the only source was from 481 
the blood of endocarditis patients, hence the species name sanguis; Latin for blood (122, 482 
124). This has been changed fairly recently to the grammatically correct version, S. 483 
sanguinis (125).  484 
IE is a relatively rare, but potentially fatal disease and can affect the heart valves 485 
or endocardium. The annual incidence ranges from 3-7 cases per 100,000 people per 486 
year and has been relatively constant, whereas the etiology of IE has changed over time 487 
(126, 127). A major concern with this disease is that mortality rates remain high; the in-488 
hospital mortality rate ranges from 15-22%, with a 5-year mortality rate around 40%. 489 
Currently, Staphylococcus aureus is the most common pathogen associated with IE. 490 
However, oral streptococci are responsible for an estimated 35-40% of cases, with 491 
sanguinis-group species the most common isolates (128). 492 
 Understanding the molecular mechanisms that might contribute to the capacity for 493 
S. sanguinis to cause IE has benefited from the availability of an excellent animal model 494 
for IE. New Zealand white rabbits can be catheterized at specific sides of the heart causing 495 
injury-induced IE after bacterial blood inoculation (129). The injury provides exposed ECM 496 
components, fibrin and platelets for attachment of the bacterial cells and subsequent 497 
aberrant clot formation, which leads to infective vegetations forming on the heart valves. 498 
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Todd Kitten’s group, Virginia Commonwealth University, have used this model to decipher 499 
molecular determinants expressed by S. sanguinis during the infection process. Using a 500 
random signature-tagged mutagenesis approach, six chromosomal loci were identified 501 
from an initial screen of 800 mutants. The mutants carried transposons in an intergenic 502 
region and in genes encoding undecaprenol kinase, homoserine kinase, anaerobic 503 
ribonucleotide reductase, adenylosuccinate lyase, and a hypothetical protein (130). The 504 
screening method is certainly elegant but has some technical limitations, since important 505 
determinants like surface-exposed proteins, which have been shown to contribute to the 506 
infection process (131), were missed. Nonetheless, the identification of determinants 507 
regarded as house-keeping genes involved in cell wall (undecaprenol kinase), amino acid 508 
(homoserine kinase) and nucleic acid (ribonucleotide reductase) synthesis suggested a 509 
potential role for these genes in pathogenesis that had not previously been appreciated. 510 
Furthermore, since these genes are not found in humans, they may represent potential 511 
targets for drug development. However, a functional analysis of the clonal structure of S. 512 
sanguinis strains isolated from the oral cavity and from subjects with IE demonstrated that 513 
house-keeping and virulence genes are subject to considerable intra-species 514 
recombination events. Thus potential drug targets in such genes may correlate with a high 515 
potential for the selection of resistant mutants (132). Interestingly, the same study also 516 
concluded that the endocarditis strains did not form a distinct sub-cluster. This supports 517 
the notion that S. sanguinis strains are human pathobionts, and thus all strains have the 518 
potential to cause IE (132). 519 
  Following on from this study, a targeted signature-tagged mutagenesis approach 520 
was employed to identify surface proteins important in IE. Thirty three proteins were 521 
classified as cell wall-associated and of these, mutants in 31 were tested in the 522 
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aforementioned rabbit model of IE, alongside mutants in 3 sortase genes (133). 523 
Interestingly, no single cell wall-associated protein was found to be essential for the 524 
development of IE (133). It may be concluded from this that no specific virulence 525 
determinants are required by S. sanguinis to cause IE. Rather, what is expressed and 526 
present during colonization of the oral cavity may be sufficient to colonize the 527 
endocardium. In support of this, surface adhesins Hsa, PadA and SspA/B from S. gordonii 528 
have been implicated in IE through their engagement with platelets, yet also contribute to 529 
the capacity for S. gordonii to bind salivary pellicle and other oral microbes (134-137). 530 
Such highly optimized genomes might explain the success of these bacteria as early 531 
colonizers, with their ability to cause IE on rare occasions coincident in their ubiquitous 532 
presence and abundance within the oral cavity.  533 
 Mutations in the genes encoding lipoprotein SsaB (a putative manganese transport 534 
protein) (38), spxA1 (encoding a global regulator involved in H2O2 production) (138) and 535 
nox (encoding an NADH oxidase that also influences H2O2 production) (139), together 536 
with the anaerobic ribonucleotide reductase already mentioned, have all been shown to 537 
impair the capacity of  S. sanguinis to cause IE. This suggests that the ability of S. 538 
sanguinis to adapt to differences in oxygen tension and the production of and resistance 539 
to reactive oxygen species are important in the development of IE, although molecular 540 
details have yet to be explained. A surface-bound nuclease, designated SWAN 541 
(streptococcal wall-anchored nuclease), has also been proposed to enable S. sanguinis 542 
to evade killing by neutrophil extracellular traps (NETs), and so promote survival both in 543 
the bloodstream and within infective vegetations (140). 544 
 Survival within the bloodstream to access extraoral sites and induction of 545 
thrombosis are key steps in IE, but these capabilities also associate S. sanguinis with 546 
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other systemic diseases. These include meningitis, following infection of the lining of the 547 
spinal cord or brain, and disseminated intravascular coagulation, in which aberrant 548 
activation of the coagulation cascade leads to the formation of small clots that can occlude 549 
blood flow to major organs and tissues (141, 142). It is also widely recognized that oral 550 
streptococci such as S. sanguinis exist in biofilm communities with Pseudomonas 551 
aeruginosa in the lungs of cystic fibrosis (CF) patients. However, with evidence that H2O2 552 
production by these streptococci can impair P. aeruginosa growth (143), the impact of S. 553 
sanguinis on CF disease progression remains to be fully understood. 554 
 555 
CONCLUSION/OUTLOOK 556 
 With the impact upon the individual, it is easy to understand why disease outcomes 557 
have historically dominated microbiological research. Nonetheless, technological 558 
advances are providing a growing appreciation for the importance of our resident 559 
microbiota. Within the oral cavity, bacteria such as S. sanguinis are ubiquitous and 560 
abundant, reflecting their evolution to be exquisitely adapted to colonization of their 561 
ecological niche. As a consequence, S. sanguinis is able to orchestrate accretion of the 562 
dental plaque biofilm, promoting the acquisition of beneficial microbes while serving as an 563 
imposing competitor to others, and ultimately serving as the foundation of a health-564 
associated biofilm community. Complex molecular mechanisms regulating physical 565 
interactions and communication networks underpin these capabilities. If these can be 566 
understood at both the molecular and ecological level, they offer immense potential for 567 
exploitation in the development of novel strategies to combat infections from a point of 568 
health as opposed to disease. 569 
 570 
  26 
REFERENCES 571 
1. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. 2005. Defining the normal 572 
bacterial flora of the oral cavity. J Clin Microbiol 43:5721-5732. 573 
2. Diaz PI, Hoare A, Hong BY. 2016. Subgingival microbiome shifts and community 574 
dynamics in periodontal diseases. J Calif Dent Assoc 44:421-435. 575 
3. Hajishengallis G, Lamont RJ. 2012. Beyond the red complex and into more 576 
complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal 577 
disease etiology. Mol Oral Microbiol 27:409-419. 578 
4. Simon-Soro A, Mira A. 2015. Solving the etiology of dental caries. Trends Microbiol 579 
23:76-82. 580 
5. Magalhaes AP, Azevedo NF, Pereira MO, Lopes SP. 2016. The cystic fibrosis 581 
microbiome in an ecological perspective and its impact in antibiotic therapy. Appl 582 
Microbiol Biotechnol 100:1163-1181. 583 
6. Stacy A, McNally L, Darch SE, Brown SP, Whiteley M. 2016. The biogeography of 584 
polymicrobial infection. Nat Rev Microbiol 14:93-105. 585 
7. Hajishengallis G, Lamont RJ. 2016. Dancing with the stars: How choreographed 586 
bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, 587 
accessory pathogens, and pathobionts. Trends Microbiol 24:477-489. 588 
8. Diaz PI, Chalmers NI, Rickard AH, Kong C, Milburn CL, Palmer RJ, Jr., 589 
Kolenbrander PE. 2006. Molecular characterization of subject-specific oral 590 
microflora during initial colonization of enamel. Appl Environ Microbiol 72:2837-591 
2848. 592 
9. Rosan B, Lamont RJ. 2000. Dental plaque formation. Microbes Infect 2:1599-1607. 593 
10. He X, McLean JS, Guo L, Lux R, Shi W. 2014. The social structure of microbial 594 
community involved in colonization resistance. ISME J 8:564-574. 595 
11. Martin R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermudez-Humaran LG. 596 
2013. Role of commensal and probiotic bacteria in human health: a focus on 597 
inflammatory bowel disease. Microb Cell Fact 12:71. 598 
12. Bik EM, Long CD, Armitage GC, Loomer P, Emerson J, Mongodin EF, Nelson KE, 599 
Gill SR, Fraser-Liggett CM, Relman DA. 2010. Bacterial diversity in the oral cavity of 600 
10 healthy individuals. ISME J 4:962-974. 601 
13. Colombo AP, Boches SK, Cotton SL, Goodson JM, Kent R, Haffajee AD, Socransky 602 
SS, Hasturk H, Van Dyke TE, Dewhirst F, Paster BJ. 2009. Comparisons of 603 
subgingival microbial profiles of refractory periodontitis, severe periodontitis, and 604 
periodontal health using the human oral microbe identification microarray. J 605 
Periodontol 80:1421-1432. 606 
14. Belda-Ferre P, Alcaraz LD, Cabrera-Rubio R, Romero H, Simon-Soro A, Pignatelli 607 
M, Mira A. 2012. The oral metagenome in health and disease. ISME J 6:46-56. 608 
15. Facklam R. 2002. What happened to the streptococci: overview of taxonomic and 609 
nomenclature changes. Clin Microbiol Rev 15:613-630. 610 
16. Hoshino T, Fujiwara T, Kilian M. 2005. Use of phylogenetic and phenotypic analyses 611 
to identify nonhemolytic streptococci isolated from bacteremic patients. J Clin 612 
Microbiol 43:6073-6085. 613 
17. Nobbs AH, Jenkinson HF, Everett DB. 2015. Generic determinants of Streptococcus 614 
colonization and infection. Infect Genet Evol 33:361-370. 615 
  27 
18. Nobbs AH, Jenkinson HF, Jakubovics NS. 2011. Stick to your gums: mechanisms of 616 
oral microbial adherence. J Dent Res 90:1271-1278. 617 
19. Nobbs AH, Lamont RJ, Jenkinson HF. 2009. Streptococcus adherence and 618 
colonization. Microbiol Mol Biol Rev 73:407-450. 619 
20. Kolenbrander PE, Palmer RJ, Jr., Rickard AH, Jakubovics NS, Chalmers NI, Diaz 620 
PI. 2006. Bacterial interactions and successions during plaque development. 621 
Periodontol 2000 42:47-79. 622 
21. Hannig M, Joiner A. 2006. The structure, function and properties of the acquired 623 
pellicle. Monogr Oral Sci 19:29-64. 624 
22. Ventura T, Cassiano LPS, Souza ESCM, Taira EA, Leite AL, Rios D, Buzalaf MAR. 625 
2017. The proteomic profile of the acquired enamel pellicle according to its location 626 
in the dental arches. Arch Oral Biol 79:20-29. 627 
23. Boehlke C, Zierau O, Hannig C. 2015. Salivary amylase - The enzyme of unspecialized 628 
euryphagous animals. Arch Oral Biol 60:1162-1176. 629 
24. Nikitkova AE, Haase EM, Scannapieco FA. 2013. Taking the starch out of oral biofilm 630 
formation: molecular basis and functional significance of salivary alpha-amylase 631 
binding to oral streptococci. Appl Environ Microbiol 79:416-423. 632 
25. Rogers JD, Haase EM, Brown AE, Douglas CW, Gwynn JP, Scannapieco FA. 1998. 633 
Identification and analysis of a gene (abpA) encoding a major amylase-binding protein 634 
in Streptococcus gordonii. Microbiology 144:1223-1233. 635 
26. Rogers JD, Palmer RJ, Jr., Kolenbrander PE, Scannapieco FA. 2001. Role of 636 
Streptococcus gordonii amylase-binding protein A in adhesion to hydroxyapatite, 637 
starch metabolism, and biofilm formation. Infect Immun 69:7046-7056. 638 
27. Liang X, Liu B, Zhu F, Scannapieco FA, Haase EM, Matthews S, Wu H. 2016. A 639 
distinct sortase SrtB anchors and processes a streptococcal adhesin AbpA with a novel 640 
structural property. Sci Rep 6:30966. 641 
28. Okahashi N, Nakata M, Terao Y, Isoda R, Sakurai A, Sumitomo T, Yamaguchi M, 642 
Kimura RK, Oiki E, Kawabata S, Ooshima T. 2011. Pili of oral Streptococcus 643 
sanguinis bind to salivary amylase and promote the biofilm formation. Microb Pathog 644 
50:148-154. 645 
29. Delius J, Trautmann S, Medard G, Kuster B, Hannig M, Hofmann T. 2017. Label-646 
free quantitative proteome analysis of the surface-bound salivary pellicle. Colloids 647 
Surf B Biointerfaces 152:68-76. 648 
30. Scannapieco FA, Bhandary K, Ramasubbu N, Levine MJ. 1990. Structural 649 
relationship between the enzymatic and streptococcal binding sites of human salivary 650 
alpha-amylase. Biochem Biophys Res Commun 173:1109-1115. 651 
31. Dawes C, Pedersen AM, Villa A, Ekstrom J, Proctor GB, Vissink A, Aframian D, 652 
McGowan R, Aliko A, Narayana N, Sia YW, Joshi RK, Jensen SB, Kerr AR, Wolff A. 653 
2015. The functions of human saliva: A review sponsored by the World Workshop on 654 
Oral Medicine VI. Arch Oral Biol 60:863-874. 655 
32. Tabak LA. 1995. In defense of the oral cavity: structure, biosynthesis, and function of 656 
salivary mucins. Annu Rev Physiol 57:547-564. 657 
33. Plummer C, Wu H, Kerrigan SW, Meade G, Cox D, Ian Douglas CW. 2005. A serine-658 
rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb. Br 659 
J Haematol 129:101-109. 660 
  28 
34. Deng L, Bensing BA, Thamadilok S, Yu H, Lau K, Chen X, Ruhl S, Sullam PM, Varki 661 
A. 2014. Oral streptococci utilize a Siglec-like domain of serine-rich repeat adhesins 662 
to preferentially target platelet sialoglycans in human blood. PLoS Pathog 663 
10:e1004540. 664 
35. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. 665 
Nat Rev Immunol 7:255-266. 666 
36. Frenkel ES, Ribbeck K. 2015. Salivary mucins in host defense and disease prevention. 667 
J Oral Microbiol 7:29759. 668 
37. Ganeshkumar N, Song M, McBride BC. 1988. Cloning of a Streptococcus sanguis 669 
adhesin which mediates binding to saliva-coated hydroxyapatite. Infect Immun 670 
56:1150-1157. 671 
38. Crump KE, Bainbridge B, Brusko S, Turner LS, Ge X, Stone V, Xu P, Kitten T. 2014. 672 
The relationship of the lipoprotein SsaB, manganese and superoxide dismutase in 673 
Streptococcus sanguinis virulence for endocarditis. Mol Microbiol 92:1243-1259. 674 
39. Gurung I, Spielman I, Davies MR, Lala R, Gaustad P, Biais N, Pelicic V. 2016. 675 
Functional analysis of an unusual type IV pilus in the Gram-positive Streptococcus 676 
sanguinis. Mol Microbiol 99:380-392. 677 
40. Aynapudi J, El-Rami F, Ge X, Stone V, Zhu B, Kitten T, Xu P. 2017. Involvement of 678 
signal peptidase I in Streptococcus sanguinis biofilm formation. Microbiology 679 
163:1306-1318. 680 
41. Auclair SM, Bhanu MK, Kendall DA. 2012. Signal peptidase I: cleaving the way to 681 
mature proteins. Protein Sci 21:13-25. 682 
42. Kreth J, Herzberg MC. 2015. Molecular principles of adhesion and biofilm formation, 683 
p 23-54. In Chavez de Paz LE, Sedgley CM, Kishen A (ed), The Root Canal Biofilm. 684 
Springer. 685 
43. Vacca Smith AM, Ng-Evans L, Wunder D, Bowen WH. 2000. Studies concerning the 686 
glucosyltransferase of Streptococcus sanguis. Caries Res 34:295-302. 687 
44. Liu J, Stone VN, Ge X, Tang M, Elrami F, Xu P. 2017. TetR family regulator brpT 688 
modulates biofilm formation in Streptococcus sanguinis. PLoS One 12:e0169301. 689 
45. Ricker A, Vickerman M, Dongari-Bagtzoglou A. 2014. Streptococcus gordonii 690 
glucosyltransferase promotes biofilm interactions with Candida albicans. J Oral 691 
Microbiol 6:23419. 692 
46. Tanzer JM, Thompson AM, Grant LP, Vickerman MM, Scannapieco FA. 2008. 693 
Streptococcus gordonii's sequenced strain CH1 glucosyltransferase determines 694 
persistent but not initial colonization of teeth of rats. Arch Oral Biol 53:133-140. 695 
47. Sulavik MC, Clewell DB. 1996. Rgg is a positive transcriptional regulator of the 696 
Streptococcus gordonii gtfG gene. J Bacteriol 178:5826-5830. 697 
48. Das T, Sehar S, Manefield M. 2013. The roles of extracellular DNA in the structural 698 
integrity of extracellular polymeric substance and bacterial biofilm development. 699 
Environ Microbiol Rep 5:778-786. 700 
49. Weerkamp AH, Uyen HM, Busscher HJ. 1988. Effect of zeta potential and surface 701 
energy on bacterial adhesion to uncoated and saliva-coated human enamel and 702 
dentin. J Dent Res 67:1483-1487. 703 
50. Kreth J, Vu H, Zhang Y, Herzberg MC. 2009. Characterization of hydrogen peroxide-704 
induced DNA release by Streptococcus sanguinis and Streptococcus gordonii. J Bacteriol 705 
191:6281-6291. 706 
  29 
51. Barnes AM, Ballering KS, Leibman RS, Wells CL, Dunny GM. 2012. Enterococcus 707 
faecalis produces abundant extracellular structures containing DNA in the absence of 708 
cell lysis during early biofilm formation. mBio 3:e00193-00112. 709 
52. Peterson BW, van der Mei HC, Sjollema J, Busscher HJ, Sharma PK. 2013. A 710 
distinguishable role of eDNA in the viscoelastic relaxation of biofilms. mBio 4:e00497-711 
00413. 712 
53. Rocco CJ, Davey ME, Bakaletz LO, Goodman SD. 2017. Natural antigenic differences 713 
in the functionally equivalent extracellular DNABII proteins of bacterial biofilms 714 
provide a means for targeted biofilm therapeutics. Mol Oral Microbiol 32:118-130. 715 
54. Blehert DS, Palmer RJ, Jr., Xavier JB, Almeida JS, Kolenbrander PE. 2003. 716 
Autoinducer 2 production by Streptococcus gordonii DL1 and the biofilm phenotype 717 
of a luxS mutant are influenced by nutritional conditions. J Bacteriol 185:4851-4860. 718 
55. Redanz S, Standar K, Podbielski A, Kreikemeyer B. 2012. Heterologous expression 719 
of sahH reveals that biofilm formation is autoinducer-2-independent in Streptococcus 720 
sanguinis but is associated with an intact activated methionine cycle. J Biol Chem 721 
287:36111-36122. 722 
56. Zhang Y, Whiteley M, Kreth J, Lei Y, Khammanivong A, Evavold JN, Fan J, 723 
Herzberg MC. 2009. The two-component system BfrAB regulates expression of ABC 724 
transporters in Streptococcus gordonii and Streptococcus sanguinis. Microbiology 725 
155:165-173. 726 
57. Camargo TM, Stipp RN, Alves LA, Harth-Chu EN, Hofling JF, Mattos-Graner RO. 727 
2018. A novel two-component system of Streptococcus sanguinis affecting functions 728 
associated with viability in saliva and biofilm formation. Infect Immun 86:e00942-17. 729 
58. Robinson JC, Rostami N, Casement J, Vollmer W, Rickard AH, Jakubovics NS. 730 
2017. ArcR modulates biofilm formation in the dental plaque colonizer Streptococcus 731 
gordonii. Mol Oral Microbiol 33:143-154. 732 
59. Vickerman MM, Iobst S, Jesionowski AM, Gill SR. 2007. Genome-wide 733 
transcriptional changes in Streptococcus gordonii in response to competence signaling 734 
peptide. J Bacteriol 189:7799-7807. 735 
60. Rodriguez AM, Callahan JE, Fawcett P, Ge X, Xu P, Kitten T. 2011. Physiological and 736 
molecular characterization of genetic competence in Streptococcus sanguinis. Mol Oral 737 
Microbiol 26:99-116. 738 
61. Yoshida Y, Palmer RJ, Yang J, Kolenbrander PE, Cisar JO. 2006. Streptococcal 739 
receptor polysaccharides: recognition molecules for oral biofilm formation. BMC Oral 740 
Health 6:S12. 741 
62. Mishra A, Devarajan B, Reardon ME, Dwivedi P, Krishnan V, Cisar JO, Das A, 742 
Narayana SV, Ton-That H. 2011. Two autonomous structural modules in the fimbrial 743 
shaft adhesin FimA mediate Actinomyces interactions with streptococci and host cells 744 
during oral biofilm development. Mol Microbiol 81:1205-1220. 745 
63. Yang J, Yoshida Y, Cisar JO. 2014. Genetic basis of coaggregation receptor 746 
polysaccharide biosynthesis in Streptococcus sanguinis and related species. Mol Oral 747 
Microbiol 29:24-31. 748 
64. Back CR, Douglas SK, Emerson JE, Nobbs AH, Jenkinson HF. 2015. Streptococcus 749 
gordonii DL1 adhesin SspB V-region mediates coaggregation via receptor 750 
polysaccharide of Actinomyces oris T14V. Mol Oral Microbiol 30:411-424. 751 
  30 
65. Jakubovics NS, Gill SR, Iobst SE, Vickerman MM, Kolenbrander PE. 2008. 752 
Regulation of gene expression in a mixed-genus community: stabilized arginine 753 
biosynthesis in Streptococcus gordonii by coaggregation with Actinomyces naeslundii. 754 
J Bacteriol 190:3646-3657. 755 
66. Zhou P, Liu J, Li X, Takahashi Y, Qi F. 2015. The sialic acid binding protein, Hsa, in 756 
Streptococcus gordonii DL1 also mediates intergeneric coaggregation with Veillonella 757 
species. PLoS One 10:e0143898. 758 
67. Hamilton IRN, S. K. C. . 1983. Stimulation of glycolysis through lactate consumption 759 
in a resting cell mixture of Streptococcus salivarius and Veillonella parvula. FEMS 760 
Microbiol Lett 20:61-65. 761 
68. Kaplan CW, Lux R, Haake SK, Shi W. 2009. The Fusobacterium nucleatum outer 762 
membrane protein RadD is an arginine-inhibitable adhesin required for inter-species 763 
adherence and the structured architecture of multispecies biofilm. Mol Microbiol 764 
71:35-47. 765 
69. Lima BP, Shi W, Lux R. 2017. Identification and characterization of a novel 766 
Fusobacterium nucleatum adhesin involved in physical interaction and biofilm 767 
formation with Streptococcus gordonii. MicrobiologyOpen 6:e444. 768 
70. Lamont RJ, El-Sabaeny A, Park Y, Cook GS, Costerton JW, Demuth DR. 2002. Role 769 
of the Streptococcus gordonii SspB protein in the development of Porphyromonas 770 
gingivalis biofilms on streptococcal substrates. Microbiology 148:1627-1636. 771 
71. Maeda KN, H.; Yamamoto, Y.; Tanaka, M.; Tanaka, J.; Minamino, N.; Shizukuishi, 772 
S. 2004. Glyceraldehyde-3-phosphate dehydrogenase of Streptococcus oralis functions 773 
as a co-adhesin for Porphyromonas gingivalis major fimbriae. Infect Immun 72:1341-774 
1348. 775 
72. Ramsey MM, Rumbaugh KP, Whiteley M. 2011. Metabolite cross-feeding enhances 776 
virulence in a model polymicrobial infection. PLoS Pathog 7:e1002012. 777 
73. Silverman RJ, Nobbs AH, Vickerman MM, Barbour ME, Jenkinson HF. 2010. 778 
Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB 779 
adhesin promotes development of mixed-species communities. Infect Immun 780 
78:4644-4652. 781 
74. Whitmore SE, Lamont RJ. 2011. The pathogenic persona of community-associated 782 
oral streptococci. Mol Microbiol 81:305-314. 783 
75. Cuadra-Saenz G, Rao DL, Underwood AJ, Belapure SA, Campagna SR, Sun Z, 784 
Tammariello S, Rickard AH. 2012. Autoinducer-2 influences interactions amongst 785 
pioneer colonizing streptococci in oral biofilms. Microbiology 158:1783-1795. 786 
76. Jang YJ, Sim J, Jun HK, Choi BK. 2013. Differential effect of autoinducer 2 of 787 
Fusobacterium nucleatum on oral streptococci. Arch Oral Biol 58:1594-1602. 788 
77. Rickard AH, Palmer RJ, Jr., Blehert DS, Campagna SR, Semmelhack MF, Egland 789 
PG, Bassler BL, Kolenbrander PE. 2006. Autoinducer 2: a concentration-dependent 790 
signal for mutualistic bacterial biofilm growth. Mol Microbiol 60:1446-1456. 791 
78. McNab R, Ford SK, El-Sabaeny A, Barbieri B, Cook GS, Lamont RJ. 2003. LuxS-792 
based signaling in Streptococcus gordonii: autoinducer 2 controls carbohydrate 793 
metabolism and biofilm formation with Porphyromonas gingivalis. J Bacteriol 794 
185:274-284. 795 
  31 
79. Bamford CV, d'Mello A, Nobbs AH, Dutton LC, Vickerman MM, Jenkinson HF. 796 
2009. Streptococcus gordonii modulates Candida albicans biofilm formation through 797 
intergeneric communication. Infect Immun 77:3696-3704. 798 
80. Zhu L, Kreth J. 2012. The role of hydrogen peroxide in environmental adaptation of 799 
oral microbial communities. Oxid Med Cell Longev 2012:717843. 800 
81. Carlsson J, Edlund MB. 1987. Pyruvate oxidase in Streptococcus sanguis under 801 
various growth conditions. Oral Microbiol Immunol 2:10-14. 802 
82. Carlsson J, Edlund MB, Lundmark SK. 1987. Characteristics of a hydrogen peroxide-803 
forming pyruvate oxidase from Streptococcus sanguis. Oral Microbiol Immunol 2:15-804 
20. 805 
83. Kreth J, Zhang Y, Herzberg MC. 2008. Streptococcal antagonism in oral biofilms: 806 
Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus 807 
mutans. J Bacteriol 190:4632-4640. 808 
84. Zheng LY, Itzek A, Chen ZY, Kreth J. 2011. Oxygen dependent pyruvate oxidase 809 
expression and production in Streptococcus sanguinis. Int J Oral Sci 3:82-89. 810 
85. Banerjee RK, Datta AG. 1986. Salivary peroxidases. Mol Cell Biochem 70:21-29. 811 
86. Marquis RE. 1995. Oxygen metabolism, oxidative stress and acid-base physiology of 812 
dental plaque biofilms. J Ind Microbiol 15:198-207. 813 
87. Herrero ER, Slomka V, Bernaerts K, Boon N, Hernandez-Sanabria E, Passoni BB, 814 
Quirynen M, Teughels W. 2016. Antimicrobial effects of commensal oral species are 815 
regulated by environmental factors. J Dent 47:23-33. 816 
88. Zheng L, Chen Z, Itzek A, Ashby M, Kreth J. 2011. Catabolite control protein A 817 
controls hydrogen peroxide production and cell death in Streptococcus sanguinis. J 818 
Bacteriol 193:516-526. 819 
89. Redanz S, Masilamani R, Cullin N, Giacaman RA, Merritt J, Kreth J. 2018. Distinct 820 
regulatory role of carbon catabolite protein A (CcpA) in oral streptococcal spxB 821 
expression. J Bacteriol 200:e00619-17. 822 
90. Zheng L, Itzek A, Chen Z, Kreth J. 2011. Environmental influences on competitive 823 
hydrogen peroxide production in Streptococcus gordonii. Appl Environ Microbiol 824 
77:4318-4328. 825 
91. Cheng X, Redanz S, Cullin N, Zhou X, Xu X, Joshi V, Koley D, Merritt J, Kreth J. 2018. 826 
Plasticity of the pyruvate node modulates hydrogen peroxide production and acid 827 
tolerance in multiple oral streptococci. Appl Environ Microbiol 84:e01697-17. 828 
92. Mark Welch JL, Rossetti BJ, Rieken CW, Dewhirst FE, Borisy GG. 2016. 829 
Biogeography of a human oral microbiome at the micron scale. Proc Natl Acad Sci U S 830 
A 113:E791-800. 831 
93. Deng H, Ding Y, Fu MD, Xiao XR, Liu J, Zhou T. 2004. Purification and 832 
characterization of sanguicin--a bacteriocin produced by Streptococcus sanguis. 833 
Sichuan Da Xue Xue Bao Yi Xue Ban 35:555-558. 834 
94. Fujimura S, Nakamura T. 1979. Sanguicin, a bacteriocin of oral Streptococcus 835 
sanguis. Antimicrob Agents Chemother 16:262-265. 836 
95. Kreth J, Merritt J, Shi W, Qi F. 2005. Competition and coexistence between 837 
Streptococcus mutans and Streptococcus sanguinis in the dental biofilm. J Bacteriol 838 
187:7193-7203. 839 
  32 
96. Ma S, Ge W, Yan Y, Huang X, Ma L, Li C, Yu S, Chen C. 2017. Effects of Streptococcus 840 
sanguinis bacteriocin on deformation, adhesion ability, and Young's modulus of 841 
Candida albicans. Biomed Res Int 2017:5291486. 842 
97. Ma S, Zhao Y, Xia X, Dong X, Ge W, Li H. 2015. Effects of Streptococcus sanguinis 843 
bacteriocin on cell surface hydrophobicity, membrane permeability, and 844 
ultrastructure of Candida thallus. Biomed Res Int 2015:514152. 845 
98. Telles DR, Karki N, Marshall MW. 2017. Oral fungal infections: Diagnosis and 846 
management. Dent Clin North Am 61:319-349. 847 
99. Fontaine L, Wahl A, Flechard M, Mignolet J, Hols P. 2015. Regulation of competence 848 
for natural transformation in streptococci. Infect Genet Evol 33:343-360. 849 
100. Rostami N, Shields RC, Yassin SA, Hawkins AR, Bowen L, Luo TL, Rickard AH, 850 
Holliday R, Preshaw PM, Jakubovics NS. 2017. A critical role for extracellular DNA 851 
in dental plaque formation. J Dent Res 96:208-216. 852 
101. Schlafer S, Meyer RL, Dige I, Regina VR. 2017. Extracellular DNA contributes to 853 
dental biofilm stability. Caries Res 51:436-442. 854 
102. Cullin N, Merritt J, Kreth J. 2017. Beyond cell devision: the ecological roles of 855 
autolysins in oral biofilm communities. Current Oral Health Reports 4:14-21. 856 
103. Itzek A, Zheng L, Chen Z, Merritt J, Kreth J. 2011. Hydrogen peroxide-dependent 857 
DNA release and transfer of antibiotic resistance genes in Streptococcus gordonii. J 858 
Bacteriol 193:6912-6922. 859 
104. Steinmoen H, Knutsen E, Havarstein LS. 2002. Induction of natural competence in 860 
Streptococcus pneumoniae triggers lysis and DNA release from a subfraction of the cell 861 
population. Proc Natl Acad Sci U S A 99:7681-7686. 862 
105. Jurcisek JA, Brockman KL, Novotny LA, Goodman SD, Bakaletz LO. 2017. 863 
Nontypeable Haemophilus influenzae releases DNA and DNABII proteins via a T4SS-864 
like complex and ComE of the type IV pilus machinery. Proc Natl Acad Sci U S A 865 
114:E6632-E6641. 866 
106. Cullin N, Redanz S, Lampi KJ, Merritt J, Kreth J. 2017. Murein hydrolase LytF of 867 
Streptococcus sanguinis and the ecological consequences of competence development. 868 
Appl Environ Microbiol 83:e01709-17. 869 
107. Veening JW, Blokesch M. 2017. Interbacterial predation as a strategy for DNA 870 
acquisition in naturally competent bacteria. Nat Rev Microbiol 15:621-629. 871 
108. Roberts AP, Kreth J. 2014. The impact of horizontal gene transfer on the adaptive 872 
ability of the human oral microbiome. Front Cell Infect Microbiol 4:124. 873 
109. Hannan S, Ready D, Jasni AS, Rogers M, Pratten J, Roberts AP. 2010. Transfer of 874 
antibiotic resistance by transformation with eDNA within oral biofilms. FEMS 875 
Immunol Med Microbiol 59:345-349. 876 
110. Zheng W, Tan MF, Old LA, Paterson IC, Jakubovics NS, Choo SW. 2017. Distinct 877 
biological potential of Streptococcus gordonii and Streptococcus sanguinis revealed by 878 
comparative genome analysis. Sci Rep 7:2949. 879 
111. Men X, Shibata Y, Takeshita T, Yamashita Y. 2016. Identification of anion channels 880 
responsible for fluoride resistance in oral streptococci. PLoS One 11:e0165900. 881 
112. Olsen I, Tribble GD, Fiehn NE, Wang BY. 2013. Bacterial sex in dental plaque. J Oral 882 
Microbiol 5:20736. 883 
113. Sukumar S, Roberts AP, Martin FE, Adler CJ. 2016. Metagenomic insights into 884 
transferable antibiotic resistance in oral bacteria. J Dent Res 95:969-976. 885 
  33 
114. Koch G, Yepes A, Forstner KU, Wermser C, Stengel ST, Modamio J, Ohlsen K, 886 
Foster KR, Lopez D. 2014. Evolution of resistance to a last-resort antibiotic in 887 
Staphylococcus aureus via bacterial competition. Cell 158:1060-1071. 888 
115. Zheng J, Ganzle MG, Lin XB, Ruan L, Sun M. 2015. Diversity and dynamics of 889 
bacteriocins from human microbiome. Environ Microbiol 17:2133-2143. 890 
116. Peyyala R, Kirakodu SS, Novak KF, Ebersole JL. 2012. Oral microbial biofilm 891 
stimulation of epithelial cell responses. Cytokine 58:65-72. 892 
117. Peyret-Lacombe A, Brunel G, Watts M, Charveron M, Duplan H. 2009. TLR2 893 
sensing of F. nucleatum and S. sanguinis distinctly triggered gingival innate response. 894 
Cytokine 46:201-210. 895 
118. Sliepen I, Van Damme J, Van Essche M, Loozen G, Quirynen M, Teughels W. 2009. 896 
Microbial interactions influence inflammatory host cell responses. J Dent Res 897 
88:1026-1030. 898 
119. Lee SH. 2015. Antagonistic effect of peptidoglycan of Streptococcus sanguinis on 899 
lipopolysaccharide of major periodontal pathogens. J Microbiol 53:553-560. 900 
120. Dworkin J. 2014. The medium is the message: interspecies and interkingdom 901 
signaling by peptidoglycan and related bacterial glycans. Annu Rev Microbiol 68:137-902 
154. 903 
121. Niven CF, Jr., White JC. 1946. A study of streptococci associated with subacute 904 
bacterial endocarditis. J Bacteriol 51:790. 905 
122. White JC, Niven CF, Jr. 1946. Streptococcus s.b.e.: A Streptococcus associated with 906 
subacute bacterial endocarditis. J Bacteriol 51:717-722. 907 
123. Washburn MR, White JC, Niven CF, Jr. 1946. Streptococcus s.b.e.: Immunological 908 
characteristics. J Bacteriol 51:723-729. 909 
124. Niven CF, Kiziuta Z, White JC. 1946. Synthesis of a polysaccharide from sucrose by 910 
Streptococcus s.b.e. J Bacteriol 51:711-716. 911 
125. Truper HG, De' Clari L. 1997. Taxonomic note: Necessary correction of specific 912 
epithets formed as substantives (nouns) “in apposition”. Int J Syst Bacteriol 47:908-913 
909. 914 
126. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr., Tleyjeh IM, Rybak MJ, Barsic 915 
B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, 916 
Fink AM, O'Gara P, Taubert KA, American Heart Association Committee on 917 
Rheumatic Fever E, Kawasaki Disease of the Council on Cardiovascular Disease 918 
in the Young CoCCCoCS, Anesthesia, Stroke C. 2015. Infective endocarditis in 919 
adults: Diagnosis, antimicrobial therapy, and management of complications: A 920 
scientific statement for healthcare professionals from the American Heart 921 
Association. Circulation 132:1435-1486. 922 
127. Hoen B, Duval X. 2013. Infective endocarditis. N Engl J Med 369:785. 923 
128. Mylonakis E, Calderwood SB. 2001. Infective endocarditis in adults. N Engl J Med 924 
345:1318-1330. 925 
129. Garrison PK, Freedman LR. 1970. Experimental endocarditis I. Staphylococcal 926 
endocarditis in rabbits resulting from placement of a polyethylene catheter in the 927 
right side of the heart. Yale J Biol Med 42:394-410. 928 
130. Paik S, Senty L, Das S, Noe JC, Munro CL, Kitten T. 2005. Identification of virulence 929 
determinants for endocarditis in Streptococcus sanguinis by signature-tagged 930 
mutagenesis. Infect Immun 73:6064-6074. 931 
  34 
131. Herzberg MC, MacFarlane GD, Gong K, Armstrong NN, Witt AR, Erickson PR, 932 
Meyer MW. 1992. The platelet interactivity phenotype of Streptococcus sanguis 933 
influences the course of experimental endocarditis. Infect Immun 60:4809-4818. 934 
132. Do T, Gilbert SC, Klein J, Warren S, Wade WG, Beighton D. 2011. Clonal structure 935 
of Streptococcus sanguinis strains isolated from endocarditis cases and the oral cavity. 936 
Mol Oral Microbiol 26:291-302. 937 
133. Turner LS, Kanamoto T, Unoki T, Munro CL, Wu H, Kitten T. 2009. Comprehensive 938 
evaluation of Streptococcus sanguinis cell wall-anchored proteins in early infective 939 
endocarditis. Infect Immun 77:4966-4975. 940 
134. Petersen HJ, Keane C, Jenkinson HF, Vickerman MM, Jesionowski A, Waterhouse 941 
JC, Cox D, Kerrigan SW. 2010. Human platelets recognize a novel surface protein, 942 
PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen 943 
receptor GPIIbIIIa. Infect Immun 78:413-422. 944 
135. Haworth JA, Jenkinson HF, Petersen HJ, Back CR, Brittan JL, Kerrigan SW, Nobbs 945 
AH. 2017. Concerted functions of Streptococcus gordonii surface proteins PadA and 946 
Hsa mediate activation of human platelets and interactions with extracellular matrix. 947 
Cell Microbiol 19:e12667. 948 
136. Kerrigan SW, Jakubovics NS, Keane C, Maguire P, Wynne K, Jenkinson HF, Cox D. 949 
2007. Role of Streptococcus gordonii surface proteins SspA/SspB and Hsa in platelet 950 
function. Infect Immun 75:5740-5747. 951 
137. Brady LJ, Maddocks SE, Larson MR, Forsgren N, Persson K, Deivanayagam CC, 952 
Jenkinson HF. 2010. The changing faces of Streptococcus antigen I/II polypeptide 953 
family adhesins. Mol Microbiol 77:276-286. 954 
138. Chen L, Ge X, Wang X, Patel JR, Xu P. 2012. SpxA1 involved in hydrogen peroxide 955 
production, stress tolerance and endocarditis virulence in Streptococcus sanguinis. 956 
PLoS One 7:e40034. 957 
139. Ge X, Yu Y, Zhang M, Chen L, Chen W, Elrami F, Kong F, Kitten T, Xu P. 2016. 958 
Involvement of NADH oxidase in competition and endocarditis virulence in 959 
Streptococcus sanguinis. Infect Immun 84:1470-1477. 960 
140. Morita C, Sumioka R, Nakata M, Okahashi N, Wada S, Yamashiro T, Hayashi M, 961 
Hamada S, Sumitomo T, Kawabata S. 2014. Cell wall-anchored nuclease of 962 
Streptococcus sanguinis contributes to escape from neutrophil extracellular trap-963 
mediated bacteriocidal activity. PLoS One 9:e103125. 964 
141. Fukushima K, Noda M, Saito Y, Ikeda T. 2012. Streptococcus sanguis meningitis: 965 
report of a case and review of the literature. Intern Med 51:3073-3076. 966 
142. Herzberg MC, Nobbs A, Tao L, Kilic A, Beckman E, Khammanivong A, Zhang Y. 967 
2005. Oral streptococci and cardiovascular disease: searching for the platelet 968 
aggregation-associated protein gene and mechanisms of Streptococcus sanguis-969 
induced thrombosis. J Periodontol 76:2101-2105. 970 
143. Whiley RA, Fleming EV, Makhija R, Waite RD. 2015. Environment and colonisation 971 
sequence are key parameters driving cooperation and competition between 972 
Pseudomonas aeruginosa cystic fibrosis strains and oral commensal streptococci. PLoS 973 
One 10:e0115513. 974 
 975 
 976 
  35 
FIGURE LEGENDS 977 
Figure 1. Summary of key Streptococcus sanguinis components important in 978 
commensalism. The schematic shows important components for the role of S. sanguinis 979 
as a commensal organism, including community integration and biofilm development, 980 
community interference and streptococcal antagonism, and interactions with salivary 981 
proteins, host cells, and the immune system. Pg, Porphyromonas gingivalis; Fn, 982 
Fusobacterium nucleatum; Sg, Streptococcus gordonii; eDNA, extracellular DNA; CSP, 983 
competence stimulating peptide. Reprinted with permission from Kreth et al. (2017). The 984 
road less traveled – defining molecular commensalism with Streptococcus sanguinis. Mol 985 
Oral Microbiol 32:181–196. doi:10.1111/omi.12170. 986 
